Item 9 Labs Corp.
INLB · OTC
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Revenue | $5,022 | $5,663 | $5,004 | $4,001 |
| % Growth | -11.3% | 13.2% | 25.1% | – |
| Cost of Goods Sold | $2,204 | $1,945 | $2,382 | $3,356 |
| Gross Profit | $2,819 | $3,718 | $2,622 | $646 |
| % Margin | 56.1% | 65.7% | 52.4% | 16.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $3,032 | $3,360 | $3,045 | $6,921 |
| SG&A Expenses | $3,354 | $3,746 | $3,333 | $7,472 |
| Sales & Mktg Exp. | $322 | $385 | $288 | $551 |
| Other Operating Expenses | $2,431 | $1,269 | $874 | $0 |
| Operating Expenses | $5,785 | $5,014 | $4,207 | $5,011 |
| Operating Income | -$2,966 | -$1,296 | -$1,585 | -$14,311 |
| % Margin | -59.1% | -22.9% | -31.7% | -357.6% |
| Other Income/Exp. Net | -$2,950 | -$2,107 | -$1,658 | -$4,168 |
| Pre-Tax Income | -$5,917 | -$3,403 | -$3,244 | -$18,479 |
| Tax Expense | -$1 | $4 | $4 | $5 |
| Net Income | -$5,911 | -$3,407 | -$3,248 | -$18,449 |
| % Margin | -117.7% | -60.2% | -64.9% | -461.1% |
| EPS | -0.058 | -0.034 | -0.033 | -0.19 |
| % Growth | -72.1% | -2.7% | 82.7% | – |
| EPS Diluted | -0.058 | -0.034 | -0.033 | -0.19 |
| Weighted Avg Shares Out | 101,840 | 101,077 | 99,157 | 96,422 |
| Weighted Avg Shares Out Dil | 101,840 | 101,077 | 99,157 | 96,422 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $0 | $0 | $0 |
| Interest Expense | $2,952 | $2,107 | $1,842 | $2,482 |
| Depreciation & Amortization | $433 | $443 | $443 | $512 |
| EBITDA | -$2,533 | -$853 | -$958 | -$15,485 |
| % Margin | -50.4% | -15.1% | -19.2% | -387% |